We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$99.8M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$86.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$48M
4
IWB icon
iShares Russell 1000 ETF
IWB
+$23M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.3M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$36.3M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$31.4M
3
AAPL icon
Apple
AAPL
+$30.2M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.6M
5
MSFT icon
Microsoft
MSFT
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 9.81%
2 Financials 8.57%
3 Healthcare 8.47%
4 Consumer Discretionary 7.78%
5 Industrials 6.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECH icon
3101
iShares MSCI Chile ETF
ECH
$1.04B
$51K ﹤0.01%
1,669
-103
-6% -$2.75K
EQBK icon
3102
Equity Bancshares
EQBK
$1.07B
$51K ﹤0.01%
2,375
-12,394
-84% -$241K
MDYV icon
3103
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.89B
$51K ﹤0.01%
914
-15,036
-94% -$759K
MGPI icon
3104
MGP Ingredients
MGPI
$379M
$51K ﹤0.01%
1,089
-11,753
-92% -$506K
POLA icon
3105
Polar Power
POLA
$6.93M
$51K ﹤0.01%
+1,538
New +$41.5K
RAPT
3106
DELISTED
RAPT Therapeutics
RAPT
$51K ﹤0.01%
325
-869
-73% -$189K
RCUS icon
3107
Arcus Biosciences
RCUS
$3.58B
$51K ﹤0.01%
1,976
-4,992
-72% -$121K
TCRT icon
3108
Alaunos Therapeutics
TCRT
$4.79M
$51K ﹤0.01%
133
-1,730
-93% -$688K
TRTX
3109
TPG RE Finance Trust
TRTX
$620M
$51K ﹤0.01%
4,730
-64,681
-93% -$613K
XGN icon
3110
Exagen
XGN
$160M
$51K ﹤0.01%
3,863
-2,501
-39% -$35.3K
TRAW icon
3111
Traws Pharma
TRAW
$9.23M
$51K ﹤0.01%
+293
New +$34K
PSTX
3112
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$51K ﹤0.01%
4,622
+2,176
+89% +$22.9K
FNCB
3113
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$51K ﹤0.01%
7,906
-11,171
-59% -$70.9K
CORR
3114
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$51K ﹤0.01%
7,364
-3,497
-32% -$21.1K
SIOX
3115
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$51K ﹤0.01%
18,306
+18,291
+121,940% +$53.3K
KRBP
3116
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$51K ﹤0.01%
+201
New +$57.1K
HTGM
3117
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$51K ﹤0.01%
+881
New +$51.3K
LEVL
3118
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
$51K ﹤0.01%
2,554
-3,456
-58% -$64.2K
MSGN
3119
DELISTED
MSG Networks Inc.
MSGN
$51K ﹤0.01%
3,445
-38,790
-92% -$434K
GLUU
3120
DELISTED
Glu Mobile Inc.
GLUU
$51K ﹤0.01%
5,703
-138,652
-96% -$1.2M
AGEN
3121
Agenus
AGEN
$315M
$50K ﹤0.01%
795
-8,774
-92% -$651K
ANGI icon
3122
Angi Inc
ANGI
$198M
$50K ﹤0.01%
382
-444
-54% -$51.5K
BDN
3123
Brandywine Realty Trust
BDN
$544M
$50K ﹤0.01%
4,199
+3,115
+287% +$33.5K
CSTE icon
3124
Caesarstone
CSTE
$109M
$50K ﹤0.01%
3,871
-21,318
-85% -$243K
INO icon
3125
Inovio Pharmaceuticals
INO
$96.2M
$50K ﹤0.01%
467
-3,448
-88% -$459K
123 124
125
126 127

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 6.4% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.